Does Shilajit Raise Testosterone? What One Human Trial Can, and Cannot, Tell Us

Direct Answer

Shilajit has one controlled human trial directly focused on testosterone markers.

Healthy men aged 45 to 55 took 250 mg of a specific purified Shilajit preparation twice daily, for a total of 500 mg daily, for 90 days.

Total testosterone, free testosterone and DHEA-S increased compared with placebo.

This supports a possible androgen-marker effect for that preparation in that population. It does not prove that Shilajit treats low testosterone or improves symptoms.

What the Trial Tested

The study was randomized, double-blind and placebo-controlled.

Participants were healthy middle-aged men. They were not selected because they had diagnosed hypogonadism.

The preparation was purified and standardised. The result should not be transferred automatically to every resin, gummy, liquid or untested product.

What Changed

The study reported statistically significant increases in total testosterone, free testosterone and DHEA-S after 90 days.

A laboratory change can be relevant. It does not automatically mean a person will notice improved energy, libido, mood, fertility or muscle growth.

The study should be interpreted according to the outcomes it actually measured.

What the Study Did Not Prove

It did not establish treatment of testosterone deficiency.

It did not prove improved sexual function, body composition, strength, fertility, quality of life or clinical symptoms.

It did not test women, younger men, older men outside the study range or people with diagnosed endocrine disorders.

Does the Percentage Increase Matter?

A percentage change can sound impressive without context.

Clinical meaning depends on the starting value, final value, symptoms, normal laboratory range and whether the change improves a meaningful health outcome.

The trial supports a biological effect on measured markers. It does not show that every participant experienced a noticeable benefit.

Product Applicability

The result applies to the specific purified preparation and dose used.

A seller cannot reasonably claim the same effect merely because a product contains Shilajit.

A resin may differ in moisture and composition. A gummy may contain a lower amount or a blend. A liquid may not state concentration clearly.

Comparable formulation, dose and batch quality matter.

The Fertility Question

A separate open-label study in men with oligospermia reported changes in semen parameters and testosterone.

It had no placebo group and did not measure pregnancy or live-birth outcomes.

This is preliminary evidence, not proof of infertility treatment.

Testosterone, Energy and Muscle

Testosterone marketing often connects one laboratory marker to energy, strength and muscle growth.

The testosterone trial did not establish these outcomes.

A separate muscular-fatigue study examined strength retention after an induced fatigue protocol. That result cannot be used to claim that testosterone caused the effect.

How Strong Is the Evidence?

The randomized, placebo-controlled design is stronger than an uncontrolled study.

The evidence base remains limited because the direct testosterone finding comes mainly from one trial using a specific proprietary preparation.

Independent replication in other populations and studies measuring symptoms would strengthen confidence.

Funding and Product-Specific Evidence

Research involving branded or proprietary ingredients is not automatically invalid.

It does increase the need for transparent funding, conflict disclosures, exact product identification and independent replication.

The correct wording is ingredient-specific, not category-wide.

Who Should Seek Medical Advice

Symptoms associated with low testosterone can have many causes.

Anyone concerned about hormone levels should seek proper testing and clinical evaluation.

Shilajit should not replace diagnosis, monitoring or established care.

Marketing Claims That Go Too Far

Avoid claims that Shilajit:

• Treats low testosterone.
• Works for every man.
• Produces guaranteed muscle growth.
• Improves libido in all users.
• Replaces testosterone therapy.
• Treats infertility.

The human trial does not support these statements.

Final Decision

The correct answer is narrower than both marketing and dismissal.

Shilajit may influence testosterone markers in healthy men aged 45 to 55 when used as a specific purified preparation at 500 mg daily for 90 days.

Whether it improves symptoms, helps other populations or applies to ordinary commercial products remains unproven.